Travere Therapeutics, Inc.
NASDAQ:TVTX
18.75 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 58.176 | 61.688 | 165.753 | 84.772 | 62.436 | 102.873 | 99.394 | 41.002 | 37.805 | 18.204 | 5.997 | 0.011 | 0.004 | 0.004 | 0 | 0.005 |
Short Term Investments
| 508.675 | 388.557 | 387.129 | 276.817 | 336.088 | 368.668 | 201.236 | 214.871 | 191.799 | 9.556 | 0.133 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 566.851 | 450.245 | 552.882 | 361.589 | 398.524 | 471.541 | 300.63 | 255.873 | 229.604 | 27.76 | 6.13 | 0.011 | 0.004 | 0.004 | 0 | 0.005 |
Net Receivables
| 21.179 | 16.646 | 16.161 | 33.067 | 18.048 | 14.49 | 13.872 | 65.359 | 59.307 | 7.959 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 9.41 | 6.922 | 7.313 | 7.608 | 6.082 | 5.619 | 5.351 | 2.826 | 2.536 | 0.801 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 19.335 | 12.624 | 6.471 | 8.143 | 6.41 | 4.028 | 5.954 | 8.294 | 10.485 | 0.813 | 1.371 | 0.022 | 0 | 0 | 0 | 0 |
Total Current Assets
| 616.775 | 486.437 | 582.827 | 410.407 | 429.064 | 495.678 | 325.807 | 332.352 | 301.932 | 37.334 | 7.501 | 0.033 | 0.004 | 0.004 | 0 | 0.005 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 25.54 | 30.049 | 34.302 | 9.418 | 2.891 | 3.146 | 3.23 | 2.587 | 0.428 | 0.671 | 0.127 | 0.024 | 0 | 0 | 0 | 0 |
Goodwill
| 0.8 | 0.9 | 0.936 | 0.936 | 0.936 | 0.936 | 0.936 | 0.936 | 0.936 | 0.936 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 103.69 | 145.038 | 148.435 | 153.189 | 157.2 | 186.691 | 184.817 | 182.043 | 161.536 | 94.266 | 12.586 | 2.197 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 104.49 | 145.038 | 148.435 | 154.125 | 158.136 | 187.627 | 185.753 | 182.979 | 162.472 | 95.201 | 12.586 | 2.197 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 15 | -16.81 | -6.425 | 21.245 | -140.814 | -2,600.655 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 32.707 | 16.81 | 6.425 | 24.328 | 141.151 | 2,600.899 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 42.108 | 11.061 | 11.069 | 33.489 | 14.709 | -24.998 | 5.556 | 7.364 | 1.995 | 1.928 | 0.04 | 0.138 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 172.138 | 186.148 | 193.806 | 197.032 | 175.736 | 213.482 | 194.539 | 192.93 | 210.468 | 98.137 | 12.998 | 2.358 | 0 | 0 | 0 | 0 |
Total Assets
| 788.913 | 672.585 | 776.633 | 607.439 | 604.8 | 709.16 | 520.346 | 525.282 | 512.4 | 135.471 | 20.499 | 2.391 | 0.004 | 0.004 | 0 | 0.005 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 41.675 | 17.29 | 15.144 | 12.133 | 26.614 | 6.954 | 18.938 | 7.522 | 7.639 | 7.124 | 3.554 | 1.023 | 0.001 | 0.001 | 0 | 0.001 |
Short Term Debt
| 4.909 | 4.433 | 3.908 | 0.357 | 2.613 | 22.457 | 0 | 0 | 0 | 40.485 | 0 | 0.885 | 0.025 | 0.025 | 0 | 0.004 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 7.096 | 11.976 | 16.268 | -0.357 | -2.613 | 49.695 | 0 | 0 | 0 | 28.883 | 0 | 2.491 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 82.553 | 91.174 | 73.624 | 68.394 | 42.221 | 18.561 | 47.792 | 68.218 | 70.52 | 23.921 | 28.103 | 0.377 | 0.04 | 0.038 | 0 | 0.028 |
Total Current Liabilities
| 177.908 | 142.163 | 124.088 | 92.66 | 95.449 | 104.621 | 85.668 | 83.262 | 85.798 | 107.539 | 35.21 | 5.799 | 0.067 | 0.064 | 0 | 0.034 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 377.263 | 403.055 | 258.078 | 215.339 | 204.861 | 195.091 | 45.077 | 44.422 | 43.902 | 43.288 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 1.835 | 10.931 | 20.379 | 0 | 0 | -32.707 | -16.81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 22.612 | 0 | 0 | 0 | 0 | 32.707 | 16.81 | 6.425 | 24.328 | 0.141 | 2.601 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 8.485 | 73.585 | 71.976 | 88.227 | 83.294 | 91.195 | 96.467 | 83.406 | 58.401 | 21.754 | 1 | 1.908 | 0 | 0.026 | 0 | 0 |
Total Non-Current Liabilities
| 410.195 | 487.571 | 350.433 | 303.566 | 288.155 | 286.286 | 141.544 | 134.253 | 126.631 | 65.183 | 3.601 | 1.908 | 0 | 0.026 | 0 | 0 |
Total Liabilities
| 588.103 | 629.734 | 474.521 | 396.226 | 383.604 | 390.907 | 227.212 | 217.515 | 212.429 | 172.722 | 38.811 | 5.799 | 0.067 | 0.064 | 0 | 0.034 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.007 | 0.006 | 0.006 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.003 | 0.002 | 0.001 | 0 | 0 | 0 | 0 |
Retained Earnings
| -1,125.622 | -1,014.223 | -765.966 | -585.875 | -416.444 | -270.017 | -177.655 | -113.056 | -65.153 | -179.175 | -67.436 | -33.612 | -0.136 | -0.121 | 0 | -0.07 |
Accumulated Other Comprehensive Income/Loss
| -1.456 | -2.907 | -0.562 | -0.902 | 0.726 | -1.529 | -1.015 | -0.49 | -0.682 | 4.286 | -0.11 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 1,327.881 | 1,059.975 | 1,068.634 | 797.985 | 636.91 | 589.795 | 471.8 | 421.309 | 365.802 | 137.636 | 49.232 | 30.203 | 0.073 | 0.061 | 0 | 0.07 |
Total Shareholders Equity
| 200.81 | 42.851 | 302.112 | 211.213 | 221.196 | 318.253 | 293.134 | 307.767 | 299.971 | -37.251 | -18.312 | -3.408 | -0.063 | -0.06 | 0 | 0 |
Total Equity
| 200.81 | 42.851 | 302.112 | 211.213 | 221.196 | 318.253 | 293.134 | 307.767 | 299.971 | -37.251 | -18.312 | -3.408 | -0.063 | -0.06 | 0 | 0 |
Total Liabilities & Shareholders Equity
| 788.913 | 672.585 | 776.633 | 607.439 | 604.8 | 709.16 | 520.346 | 525.282 | 512.4 | 135.471 | 20.499 | 2.391 | 0.004 | 0.004 | 0 | 0.005 |